In Depth 13 Mar 2024
From LSD to healing minds: Where are we standing in psychedelic drug development?
Delve into the growing sector of psychedelic drug development to find out where we are coming from, and where we are standing in the field.
Search Results for: drug development
More sustainable drug development and lab sustainability
From reducing carbon footprints to optimising costs, explore innovative solutions for sustainable drug discovery and development!
How a virtual company leveraged data to accelerate drug development for neurodegenerative diseases
Find out how the virtual biotech company Libra Therapeutics leveraged data to accelerate drug development for neurodegenerative diseases.
Opinion 29 Nov 2023
Redefining drug development: the trailblazing evolution of the pharmaceutical industry
Drug discovery and development is a long, costly, and high-risk process that takes over 10 to 15 years with an average cost of over $1 to $2 billion for each new drug to be approved for clinical use. For any pharmaceutical company or academic institution, it is a big achievement to advance a drug candidate […]
ADVERTISEMENT
News and Trends 23 Jun 2023
SandboxAQ launches new division to boost drug development
After several years of stealth development, SandboxAQ has announced its bio-pharma molecular simulation division, AQBioSim, and some of its customers. The division is helping bio-pharma and research institutions achieve breakthroughs in treatments for cancer, Alzheimer’s, Parkinson’s, and other conditions. The company is currently working with biopharma companies and university research labs, including AstraZeneca, Sanofi and […]
News and Trends 15 Jun 2023
New way of identifying proteins supports drug development
All living cells contain proteins with different functions, depending on the type of cell. Researchers at the University of Gothenburg in Sweden have discovered a way to identify proteins even without looking at their structure. They say their method is faster, easier and more reliable than previous methods. Currently, the general view is that each […]
Interview 2 May 2023
Generative AI in novel drug development
Within months of its release, ChatGPT is finding use in almost all industries, including biotech, pharma, and healthcare. ChatGPT and other large language models like it belong to a family of artificial intelligence (AI) technologies dubbed generative AI. Based on statistical associations gathered from large datasets, generative AI models produce content similar to the data […]
Opinion 8 Mar 2023
Should pharma be listening to social media to drive drug development?
By Thierry Escudier, consultant and strategic leader at The Pistoia Alliance The move towards patient centricity is gathering momentum, and digital technology is playing a huge role in this shift. Decentralized clinical trials that employ mobile apps and wearable devices to monitor patients and make results gathering easier are a particularly successful example of how […]
News and Trends 24 Nov 2022
AI works on artificial DNA for future drug development
With the help of artificial intelligence (AI), researchers at Chalmers University of Technology in Sweden have succeeded in designing synthetic DNA that controls the cells’ protein production. The technology can contribute to the development and production of vaccines, drugs for severe diseases, as well as alternative food proteins much faster and at significantly lower costs […]
News and Trends 24 Oct 2022
New method of observing cell transport could inspire drug development
Membrane proteins are key targets for many drugs. Some of them, called transporters, move certain substances in and out of the cellular environment. Yet, extracting and storing them for observation is particularly complex. A team from the University of Geneva (UNIGE) in Switzerland, in collaboration with the University of Zurich (UZH), has developed an innovative […]
News and Trends 28 Sep 2022
Optics11 Life receives €5 million in funding for drug development and rollout of products
Expanded offerings for drug development and regenerative medicines will be the focus of €5 million ($4.8 million) funding raised by Optics11 Life. The funding from Forward.ONE and returning investor, Value Creation Capital, was announced today (September 28) and will support the rollout of new products applying the company’s technology for experiments at scale requiring high-throughput […]
News and Trends 1 Sep 2022
New discovery could lead to drug development for brain cancer
According to researchers, a study at Tel Aviv University in Israel effectively eradicated glioblastoma, a highly lethal type of brain cancer. The researchers achieved the outcome using a method they developed based on their discovery of two critical mechanisms in the brain that support tumor growth and survival: one protects cancer cells from the immune […]